Close

Allscripts (MDRX) PT Raised to $13 at Cantor Fitzgerald Following In-Line 4Q Results

February 17, 2017 7:22 AM EST Send to a Friend
Cantor Fitzgerald analyst Steven Halper reiterates Neutral rating and raises price target on Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login